EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Claudin‐11–Mediated Hypomyelinating Leukodystrophy 22: New Insights Into Pathogenic Mechanisms

Fabio Acquaviva, Serena Troisi, Gabriella Errichiello, Carmela Russo, Eugenio Maria Covelli, Maria Anna Siano, Maria Rosaria Manna, Alfonsina Tirozzi iD, Daniele De Brasi, Antonio Varone

Clinical Genetics · 2026

DOI: 10.1111/cge.70212 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Genetics, 2026. Verfasst von Fabio Acquaviva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Unit, Department of General and Emergency Pediatrics, AORN Santobono-Pausilipon, Naples, Italy. Hauptthemen laut MEDLINE: Claudins, Developmental Disabilities, Genetic Predisposition to Disease, Hereditary Central Nervous System Demyelinating Diseases. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CLDN11 has recently been associated with hypomyelinating leukodystrophy caused by de novo stop‐loss variants. Here, we present a new case involving a homozygous variant in order to expand the genetic and clinical spectrum of the disease. We performed a comprehensive clinical, neuroradiological, and genetic evaluation in a child presenting with global developmental delay. Brain MRI and MR spectroscopy were obtained, and next‐generation sequencing with parental segregation analysis was conducted. The patient presented with developmental delay, hypotonia, limb hypertonia, esotropia, and an absence of early developmental milestones in infancy, followed by partial motor improvement and persistent language and cognitive impairment. Brain MRI revealed diffuse supratentorial hypomyelination with stability over time. Genetic analysis identified a novel homozygous CLDN11 start‐loss variant (c.1A>G; p.Met1Val), which is predicted to result in biallelic loss of function. Both parents were found to be heterozygous carriers. This case supports an autosomal recessive mechanism of CLDN11 ‐related disease, which differs from the dominant stop‐loss variants reported previously. The phenotype partially overlaps with that of earlier cases, but is characterized by milder motor involvement and more pronounced cognitive impairment. These findings broaden the mutational spectrum and suggest distinct pathogenic mechanisms, with important implications for diagnosis and genetic counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClaudinsDevelopmental DisabilitiesGenetic Predisposition to DiseaseHereditary Central Nervous System Demyelinating DiseasesChild, PreschoolFemaleHumansBrainHomozygoteMagnetic Resonance ImagingMutationPedigreePhenotypePsychomotor DisordersAntiportersAmino Acid Transport Systems, AcidicMitochondrial Diseases

Stichwörter der Autor:innen

CLND11claudin‐11hypomyelinating leukodystrophy 22inheritance mechanisms

Substanzen

ClaudinsCLDN11 protein, humanAntiportersAmino Acid Transport Systems, Acidic

Autor:innen und Institutionen

  • Medical Genetics Unit, Department of General and Emergency Pediatrics, AORN Santobono-Pausilipon, Naples, Italy.
  • Pediatric Neurology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Child Neuropsychiatry Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Pediatric Neuroradiology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Rehabilitation Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.

ORCID-Profile: Alfonsina Tirozzi

Zitieren

APA

Acquaviva, F., Troisi, S., Errichiello, G., Russo, C., Covelli, E. M., Siano, M. A., Manna, M. R., Tirozzi, A., De Brasi, D., & Varone, A. (2026). Claudin‐11–Mediated Hypomyelinating Leukodystrophy 22: New Insights Into Pathogenic Mechanisms. Clinical Genetics. https://doi.org/10.1111/cge.70212

Vancouver

Acquaviva F, Troisi S, Errichiello G, Russo C, Covelli EM, Siano MA, et al. Claudin‐11–Mediated Hypomyelinating Leukodystrophy 22: New Insights Into Pathogenic Mechanisms. Clinical Genetics. 2026. doi:10.1111/cge.70212

BibTeX
@article{Acquaviva2026,
  author = {Acquaviva, Fabio and Troisi, Serena and Errichiello, Gabriella and Russo, Carmela and Covelli, Eugenio Maria and Siano, Maria Anna and Manna, Maria Rosaria and Tirozzi, Alfonsina and De Brasi, Daniele and Varone, Antonio},
  title = {Claudin‐11–Mediated Hypomyelinating Leukodystrophy 22: New Insights Into Pathogenic Mechanisms},
  journal = {Clinical Genetics},
  year = {2026},
  doi = {10.1111/cge.70212}
}
Kostenlos starten →